• Human FOLR2 protein (Recombinant) (C-His) (STJP002333)
  • Human FOLR2 protein (Recombinant) (C-His) (STJP002333)
  • Human FOLR2 protein (Recombinant) (C-His) (STJP002333)
  • Human FOLR2 protein (Recombinant) (C-His) (STJP002333)

Human FOLR2 protein (Recombinant) (C-His) (STJP002333)

SKU:
STJP002333-100

Shipping:
Free Shipping
Current Stock:
Host: HEK293 cells
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Recombinant-Human FOLR2-C-His protein was developed from hek293 cells and has a target region of C-His. For use in research applications.
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Endotoxin: Less than 1EU per Mu g by the LAL method.
Gene Symbol: FOLR2
Gene ID: 2350
Uniprot ID: FOLR2_HUMAN
Immunogen Region: Thr17-Met228
Immunogen: Recombinant Human FOLR2 Protein is expressed from Expi293 with His tag at the C-terminal.;It contains Thr17-Met228.
Post Translational Modifications N-glycosylated.
Function Binds to folate and reduced folic acid derivatives and mediates delivery of 5-methyltetrahydrofolate and folate analogs into the interior of cells. Has high affinity for folate and folic acid analogs at neutral pH. Exposure to slightly acidic pH after receptor endocytosis triggers a conformation change that strongly reduces its affinity for folates and mediates their release.
Protein Name Folate Receptor Beta
Fr-Beta
Folate Receptor 2
Folate Receptor - Fetal/Placental
Placental Folate-Binding Protein
Fbp
Database Links Reactome: R-HSA-163125
Reactome: R-HSA-196757
Cellular Localisation Cell Membrane
Lipid-Anchor
Gpi-Anchor
Secreted
Alternative Protein Names Folate Receptor Beta protein
Fr-Beta protein
Folate Receptor 2 protein
Folate Receptor - Fetal/Placental protein
Placental Folate-Binding Protein protein
Fbp protein
FOLR2 protein

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance